Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DHT | CRVL |
|---|---|---|
| Price | $23.82 | $76.00 |
| Change today | ▲ 0.59% | ▲ 0.70% |
| Market cap | $3.84B | $3.84B |
| Return, 3 months | +47.0% | +18.1% |
| Return, year to date | +121.1% | +12.3% |
| Return, 1 year | +132.3% | +1.9% |
| P/E (TTM) | 8.1 | 33.8 |
| P/B | 2.9 | 9.4 |
| P/E percentile vs own 5y | 25th | – |
| Dividend yield | 6.17% | – |
| Revenue growth (YoY, latest qtr) | -12.8% | – |
| Net profit growth (YoY) | +16.3% | – |
| Gross margin | 38.3% | – |
| Operating margin | 34.5% | – |
| Net margin | 42.3% | – |
| Return on equity | – | – |
| Analyst target vs. price | -1.3% | – |
| Analyst buy share | 50% | – |
| RSI (14) | 72 | 72 |
| 30-day volatility | 37.7% | 22.4% |
| Max drawdown, 1 year | -17.2% | -42.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
